Solving Fragmentation: Expert Insights On Future-Proofing The Advanced Therapy Supply Chain

As advanced therapies transform patient care, their success increasingly depends on more than scientific breakthroughs alone. Every personalized dose relies on a complex ecosystem of collection sites, couriers, cryopreservation facilities, biostorage providers, and manufacturing centers. Yet when these critical elements operate in silos, timelines are delayed, and patient material is put at risk.

This expert-led webinar will bring together leaders from across the cell and gene therapy landscape to discuss how forward-thinking organizations are shifting from fragmented logistics to integrated, purpose-built platforms. Featuring real-world perspectives from Cryoport Systems, Carrigent, and SK pharmteco, the session will explore how defragmenting the supply chain can strengthen resilience, enhance scalability, and support the entire product lifecycle.

Attendees will gain practical insights into the operational and regulatory implications of fragmented versus integrated supply models, strategies for standardizing patient material collection, cryopreservation, and storage, and the benefits of early alignment between logistics and manufacturing to reduce variability and accelerate commercialization.

Whether you are preparing for your first clinical shipment or scaling for global distribution, this conversation will provide actionable strategies to streamline operations, improve reliability, and ultimately deliver better outcomes for patients.